Gyomor- és nyelőcsőrák: vizsgálatok itt: Kína
723 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisNot yet taking people in KínaIBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric Cancer
- Where
- Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 50
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT07361991 - No phaseCsak meghívásosProlonged Extubation in Gastric Cancer With OSA
- Where
- Jinan
- Életkor
- 18 év to 85 év
- People
- 240
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT07362706 - 2. fázisTaking peopleRadiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 100
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT05978193 - 3. fázisTaking peopleJS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.
- Where
- Anyang, Baotou, Beijing, Binzhou, Changchun, Changsha, Chengdu, Datong, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Ji'nan, Jinan, Kunming, Langfang, Lanzhou, Linfen, Linyi, Luoyang, Meizhou, Nanchang, Nanjing, Nanning, Nanyang, Puyang, Qingdao, Sanmenxia, Shanghai, Shantou, Shenyang, Shijiazhuang, Suining, Taiyuan, Tangshan, Ürümqi, Weifang, Wenzhou, Wuhan, Wuwei, Wuxi, Xi’an, Xiangyang, Xuzhou, Yangzhou, Yibin, Yichang, Yinchuan, Zhengzhou, Zhoukou
- Életkor
- 18 év and over
- People
- 560
- Run by
- Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT07284134 - No phaseTaking peopleLaryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
- Where
- Hangzhou
- People
- 1200
- Run by
- Zhejiang University
See details and how to joinNCT07359586 - 3. fázisTaking peopleChemoradiotherapy in Esophageal or Esophagogastric Junction Cancer
- Where
- Anyang, Beijing, Changsha, Nanjing
- Életkor
- 18 év and over
- People
- 2000
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT04821778 - 3. fázisTaking peopleNeoadjuvant Treatment Modalities in Esophageal Cancer
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 2000
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT04821843 - 2. fázisNot yet taking people in KínaSynergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer
- Where
- Shanghai
- Életkor
- 18 év to 79 év
- People
- 84
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06468280 - 1/2. fázisTaking peopleA First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 170
- Run by
- 3H Pharmaceuticals Co., Ltd.
See details and how to joinNCT07354711 - Korai 1. fázisCsak meghívásosClinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Fuzhou
- Életkor
- 18 év to 75 év
- People
- 100
- Run by
- Fujian Medical University
See details and how to joinNCT07356466 - 3. fázisTaking peopleStudy to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 550
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT04342910 - No phaseTaking peoplePrecision Palliative Care for Patients With Advanced Esophageal Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 624
- Run by
- Fudan University
See details and how to joinNCT06787313 - 1. fázisTaking peopleA Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
- Where
- Hangzhou, Shanghai, Wuhan, Zhengzhou
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Phrontline Biopharma
See details and how to joinNCT07181473 - 3. fázisNot yet taking people in KínaRobotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 335
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07331454 - 1/2. fázisNot yet taking people in KínaA Hypoxia-Inducible CAR-T Cell Targeting AXL and CD73 for Advanced Gastric Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 42
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07333573 - 1/2. fázisTaking peopleFruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer
- Where
- Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 45
- Run by
- Henan Cancer Hospital
See details and how to joinNCT07334431 - 2. fázisTaking peopleA Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer
- Where
- Hangzhou, Shijiazhuang
- Életkor
- 18 év to 70 év
- People
- 200
- Run by
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07110571 - 2. fázisNot yet taking people in KínaSpirulina Derivative for Radiation Esophagitis
- Where
- Chengdu
- Életkor
- 18 év and over
- People
- 70
- Run by
- West China Hospital
See details and how to joinNCT07324018 - 2. fázisTaking peoplePerioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Zhejiang Cancer Hospital
See details and how to joinNCT07325630 - 3. fázisTaking peopleTDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 432
- Run by
- Fudan University
See details and how to joinNCT06676449 - 1/2. fázisTaking peopleHypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcinoma
- Where
- Chengdu, Xiamen
- Életkor
- 18 év and over
- People
- 84
- Run by
- West China Hospital
See details and how to joinNCT07182565 - 2. fázisTaking peopleIparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 32
- Run by
- Beijing Friendship Hospital
See details and how to joinNCT07315854 - 1. fázisTaking peopleNeoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02)
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 60
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07317609 - 3. fázisNot yet taking people in KínaClinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastric Cancer
- Where
- Fuzhou
- Életkor
- 18 év to 75 év
- People
- 118
- Run by
- Fujian Medical University
See details and how to joinNCT07314203 - 2. fázisNot yet taking people in KínaQL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 74
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07315035